Form 8-K - Current report:
SEC Accession No. 0001144204-17-045220
Filing Date
2017-08-25
Accepted
2017-08-25 17:00:36
Documents
1
Period of Report
2017-08-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K v473935_8k.htm 8-K 16364
  Complete submission text file 0001144204-17-045220.txt   17542
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 171052572
SIC: 2834 Pharmaceutical Preparations